E2F1 and hepatocellular carcinoma: Analysis of the dichotomized group according to the level of E2F1 expression indicated that the top 30th percentile (N = 80; “high E2F1”) showed distinct clinical features from the rest of the HCC patients (N = 158; “low E2F1”).